Jinxin Fertility Group Limited (JXR) disclosed a fresh share buyback on 21 October 2026, repurchasing 2.22 million ordinary shares on the Hong Kong Stock Exchange at prices between HKD 2.21 and HKD 2.24. The transaction cost HKD 4.94 million and the repurchased shares have been retained as treasury stock.
Following the latest repurchase, JXR’s treasury shares increased from 50.97 million to 53.19 million. The company’s issued share capital (excluding treasury shares) declined marginally by 0.08 percent to 2.65 billion shares, while the total number of issued shares remained unchanged at 2.71 billion.
The buyback forms part of the mandate approved on 25 June 2026, which authorised repurchases of up to 262.51 million shares. Cumulative repurchases under this mandate now stand at 65.73 million shares, equivalent to 2.50 percent of the company’s issued shares on the mandate date. A 30-day moratorium on new share issues or treasury-share sales remains in effect until 20 November 2026.
In addition to treasury stock, JXR holds 65.97 million shares previously repurchased but not yet cancelled, reflecting a series of transactions executed between March and August 2026 at volume-weighted average prices ranging from HKD 1.97 to HKD 2.47 per share.
Comments